Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Guselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsSkin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, skin disorder, spondylitis, vertebral column disorderRecruitingPhase 32025-10-09NCT05669833

2 results · Page 1 of 1

Swipe the table sideways for more columns.

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Cincy ArthritisBlue AshUnited States1
Cumberland RheumatologyCrossvilleUnited States2
Family Arthritis CenterLoxahatchee GrovesUnited States1
Healing RheumatologyPlant CityUnited States1
Heritage Rheumatology and Arthritis CareColleyvilleUnited States2
Hospital at the University of PennsylvaniaPhiladelphiaUnited States2
New York UniversityNew YorkUnited States26
Parris and AssociatesLilburnUnited States1
Southern Ohio RheumatologyWheelersburgUnited States2
Southwest Florida RheumatologyRiverviewUnited States2
Texas Arthritis CenterEl PasoUnited States7
University of Massachusetts Chan Medical SchoolWorcesterUnited States33
University of Nebraska Medical CenterOmahaUnited States397
University of UtahSalt Lake CityUnited States106